218 related articles for article (PubMed ID: 27721502)
1. Calcium dysregulation contributes to neurodegeneration in FTLD patient iPSC-derived neurons.
Imamura K; Sahara N; Kanaan NM; Tsukita K; Kondo T; Kutoku Y; Ohsawa Y; Sunada Y; Kawakami K; Hotta A; Yawata S; Watanabe D; Hasegawa M; Trojanowski JQ; Lee VM; Suhara T; Higuchi M; Inoue H
Sci Rep; 2016 Oct; 6():34904. PubMed ID: 27721502
[TBL] [Abstract][Full Text] [Related]
2. Integrative system biology analyses of CRISPR-edited iPSC-derived neurons and human brains reveal deficiencies of presynaptic signaling in FTLD and PSP.
Jiang S; Wen N; Li Z; Dube U; Del Aguila J; Budde J; Martinez R; Hsu S; Fernandez MV; Cairns NJ; ; ; Harari O; Cruchaga C; Karch CM
Transl Psychiatry; 2018 Dec; 8(1):265. PubMed ID: 30546007
[TBL] [Abstract][Full Text] [Related]
3. Defective proteostasis in induced pluripotent stem cell models of frontotemporal lobar degeneration.
Mahali S; Martinez R; King M; Verbeck A; Harari O; Benitez BA; Horie K; Sato C; Temple S; Karch CM
Transl Psychiatry; 2022 Dec; 12(1):508. PubMed ID: 36494352
[TBL] [Abstract][Full Text] [Related]
4. Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons.
Oakley DH; Klickstein N; Commins C; Chung M; Dujardin S; Bennett RE; Hyman BT; Frosch MP
J Neurosci; 2021 May; 41(19):4335-4348. PubMed ID: 33893219
[TBL] [Abstract][Full Text] [Related]
5. Mitotic defects lead to neuronal aneuploidy and apoptosis in frontotemporal lobar degeneration caused by MAPT mutations.
Caneus J; Granic A; Rademakers R; Dickson DW; Coughlan CM; Chial HJ; Potter H
Mol Biol Cell; 2018 Mar; 29(5):575-586. PubMed ID: 29282277
[TBL] [Abstract][Full Text] [Related]
6. Tau inhibits mitochondrial calcium efflux and makes neurons vulnerable to calcium-induced cell death.
Britti E; Ros J; Esteras N; Abramov AY
Cell Calcium; 2020 Mar; 86():102150. PubMed ID: 31918031
[TBL] [Abstract][Full Text] [Related]
7. MAPT genotype-dependent mitochondrial aberration and ROS production trigger dysfunction and death in cortical neurons of patients with hereditary FTLD.
Korn L; Speicher AM; Schroeter CB; Gola L; Kaehne T; Engler A; Disse P; Fernández-Orth J; Csatári J; Naumann M; Seebohm G; Meuth SG; Schöler HR; Wiendl H; Kovac S; Pawlowski M
Redox Biol; 2023 Feb; 59():102597. PubMed ID: 36599286
[TBL] [Abstract][Full Text] [Related]
8. A Comprehensive Resource for Induced Pluripotent Stem Cells from Patients with Primary Tauopathies.
Karch CM; Kao AW; Karydas A; Onanuga K; Martinez R; Argouarch A; Wang C; Huang C; Sohn PD; Bowles KR; Spina S; Silva MC; Marsh JA; Hsu S; Pugh DA; Ghoshal N; Norton J; Huang Y; Lee SE; Seeley WW; Theofilas P; Grinberg LT; Moreno F; McIlroy K; Boeve BF; Cairns NJ; Crary JF; Haggarty SJ; Ichida JK; Kosik KS; Miller BL; Gan L; Goate AM; Temple S;
Stem Cell Reports; 2019 Nov; 13(5):939-955. PubMed ID: 31631020
[TBL] [Abstract][Full Text] [Related]
9. Genetically engineered MAPT 10+16 mutation causes pathophysiological excitability of human iPSC-derived neurons related to 4R tau-induced dementia.
Kopach O; Esteras N; Wray S; Abramov AY; Rusakov DA
Cell Death Dis; 2021 Jul; 12(8):716. PubMed ID: 34274950
[TBL] [Abstract][Full Text] [Related]
10. Generation of a human induced pluripotent stem cell-based model for tauopathies combining three microtubule-associated protein TAU mutations which displays several phenotypes linked to neurodegeneration.
García-León JA; Cabrera-Socorro A; Eggermont K; Swijsen A; Terryn J; Fazal R; Nami F; Ordovás L; Quiles A; Lluis F; Serneels L; Wierda K; Sierksma A; Kreir M; Pestana F; Van Damme P; De Strooper B; Thorrez L; Ebneth A; Verfaillie CM
Alzheimers Dement; 2018 Oct; 14(10):1261-1280. PubMed ID: 30036493
[TBL] [Abstract][Full Text] [Related]
11. High-content image-based analysis and proteomic profiling identifies Tau phosphorylation inhibitors in a human iPSC-derived glutamatergic neuronal model of tauopathy.
Cheng C; Reis SA; Adams ET; Fass DM; Angus SP; Stuhlmiller TJ; Richardson J; Olafson H; Wang ET; Patnaik D; Beauchamp RL; Feldman DA; Silva MC; Sur M; Johnson GL; Ramesh V; Miller BL; Temple S; Kosik KS; Dickerson BC; Haggarty SJ
Sci Rep; 2021 Aug; 11(1):17029. PubMed ID: 34426604
[TBL] [Abstract][Full Text] [Related]
12. Brain perfusion patterns in familial frontotemporal lobar degeneration.
Seelaar H; Papma JM; Garraux G; de Koning I; Reijs AE; Valkema R; Rozemuller AJ; Salmon E; van Swieten JC
Neurology; 2011 Jul; 77(4):384-92. PubMed ID: 21753175
[TBL] [Abstract][Full Text] [Related]
13. MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations.
Biswas MHU; Almeida S; Lopez-Gonzalez R; Mao W; Zhang Z; Karydas A; Geschwind MD; Biernat J; Mandelkow EM; Futai K; Miller BL; Gao FB
Stem Cell Reports; 2016 Sep; 7(3):316-324. PubMed ID: 27594586
[TBL] [Abstract][Full Text] [Related]
14. Frontotemporal Lobar Degeneration.
Premi E; Padovani A; Borroni B
Adv Exp Med Biol; 2012; 724():114-27. PubMed ID: 22411238
[TBL] [Abstract][Full Text] [Related]
15. Pathological Progression Induced by the Frontotemporal Dementia-Associated R406W Tau Mutation in Patient-Derived iPSCs.
Nakamura M; Shiozawa S; Tsuboi D; Amano M; Watanabe H; Maeda S; Kimura T; Yoshimatsu S; Kisa F; Karch CM; Miyasaka T; Takashima A; Sahara N; Hisanaga SI; Ikeuchi T; Kaibuchi K; Okano H
Stem Cell Reports; 2019 Oct; 13(4):684-699. PubMed ID: 31543469
[TBL] [Abstract][Full Text] [Related]
16. Genetic correction of tauopathy phenotypes in neurons derived from human induced pluripotent stem cells.
Fong H; Wang C; Knoferle J; Walker D; Balestra ME; Tong LM; Leung L; Ring KL; Seeley WW; Karydas A; Kshirsagar MA; Boxer AL; Kosik KS; Miller BL; Huang Y
Stem Cell Reports; 2013; 1(3):226-34. PubMed ID: 24319659
[TBL] [Abstract][Full Text] [Related]
17. Human iPSC-Derived Neuronal Model of Tau-A152T Frontotemporal Dementia Reveals Tau-Mediated Mechanisms of Neuronal Vulnerability.
Silva MC; Cheng C; Mair W; Almeida S; Fong H; Biswas MHU; Zhang Z; Huang Y; Temple S; Coppola G; Geschwind DH; Karydas A; Miller BL; Kosik KS; Gao FB; Steen JA; Haggarty SJ
Stem Cell Reports; 2016 Sep; 7(3):325-340. PubMed ID: 27594585
[TBL] [Abstract][Full Text] [Related]
18. Elevated 4R-tau in astrocytes from asymptomatic carriers of the MAPT 10+16 intronic mutation.
Setó-Salvia N; Esteras N; de Silva R; de Pablo-Fernandez E; Arber C; Toomey CE; Polke JM; Morris HR; Rohrer JD; Abramov AY; Patani R; Wray S; Warner TT
J Cell Mol Med; 2022 Feb; 26(4):1327-1331. PubMed ID: 34951131
[TBL] [Abstract][Full Text] [Related]
19. Sporadic four-repeat tauopathy with frontotemporal lobar degeneration, Parkinsonism, and motor neuron disease: a distinct clinicopathological and biochemical disease entity.
Fu YJ; Nishihira Y; Kuroda S; Toyoshima Y; Ishihara T; Shinozaki M; Miyashita A; Piao YS; Tan CF; Tani T; Koike R; Iwanaga K; Tsujihata M; Onodera O; Kuwano R; Nishizawa M; Kakita A; Ikeuchi T; Takahashi H
Acta Neuropathol; 2010 Jul; 120(1):21-32. PubMed ID: 20140439
[TBL] [Abstract][Full Text] [Related]
20. Tau physiology and pathomechanisms in frontotemporal lobar degeneration.
Bodea LG; Eckert A; Ittner LM; Piguet O; Götz J
J Neurochem; 2016 Aug; 138 Suppl 1(Suppl Suppl 1):71-94. PubMed ID: 27306859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
